Oats, dried prunes, tuna fish, milk, chicken, bread, peanuts, and chocolate are fabulous foods that enrich our everyday meals. But apart from their culinary properFes, they are also great sources of tryptophan. Tryptophan is an amino acid which is used by cells either as a building block for the synthesis of proteins or as a precursor in several metabolic pathways. Serotonin -our natural mood stabiliser -is an example of a product generated from tryptophan absorbed in our diet. However, the great majority of ingested tryptophan is used by a metabolic process called the kynurenine pathway. The final products of this process provide an ultra violet (UV) filter in our eyes which protects the reFna from UV damage and are also used by cells in a diversity of other fundamental reacFons. More interesFngly, several intermediate products (metabolites) of the kynurenine pathway cause either damaging or protecFve effects to nerve cells (neurons). Indeed, the pathway can be divided into a "bad" or toxic secFon in which the metabolites 3-hydoxykynurenine and quinolinic acid are produced and a "good" or protecFve secFon which produces kynurenic acid (KYNA).
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NeurodegeneraFve disorders is an umbrella term used to idenFfy several human pathologies characterised by the progressive degeneraFon of neurons which ulFmately culminate with their death in selecFve regions of the brain. Some examples of these pathologies are Alzheimer's, Parkinson's and HunFngton's diseases -for which there are no cures. Although disease-specific clinical traits are shown by paFents, all of these disorders are characterised by aberrant changes in levels of kynurenine metabolites. Indeed, while in normal health a fine balance between the "bad" and "good" metabolites is maintained, a shi] towards the producFon of "bad" metabolites is observed in the brain of paFents. Thus, exciFng quesFons can be raised: Can we intervene to decrease the producFon of "bad" metabolites and increase levels of the "good" metabolite? Would this intervenFon be a valuable therapeuFc avenue for treaFng these devastaFng diseases?
In order to address this quesFon, we needed a simple yet reliable model to study. We f o u n d t h i s i n t h e c o m m o n f r u i t fl y Drosophila melanogaster, a robust system used for many decades to study several cellular processes relevant to human disease. InteresFngly, fruit flies do not develop neurodegeneraFve diseases, but these can o]en be mimicked by inserFng the defecFve human genes into flies and using appropriate geneFc and molecular tools.
We focused on how diet can improve the condiFon of flies displaying symptoms of HunFngton's disease. We found that an enriched tryptophan diet protects these flies from neuron loss by shi]ing the kynurenine metabolism towards producFon of the "good" metabolite KYNA. Similarly, by raising the dosage of the enzyme responsible for producing KYNA, an improvement in HunFngton's disease-related defects was observed. Thus, the "good" metabolite can counteract the effects of the "bad" metabolites, prevent cells from dying, and thereby improve health in the flies.
Are there any other ways to raise levels of the protecFve metabolite in the flies? We demonstrated that "switching off" two criFcal enzymes -called TDO and KMO -of this pathway led to increased levels of the protecFve 1 :Department of GeneFcs, University of Leicester, Leicester LE1 7RH, UK This Break was edited by Carlos Javier Rivera-Rivera, ScienFfic Editor -TheScienceBreaker metabolite. This change causes reversion of several disease-related defects not only in HunFngton's disease model flies, but also in fly models of Alzheimer's and Parkinson's diseases. Furthermore, drug intervenFons which arrest TDO and KMO acFviFes reduce neuronal death and other symptoms displayed by these neurodegeneraFve fly models.
As the current worldwide populaFon lives longer, the number of people suffering from these neurodegeneraFve disorders is sadly increasing. These exciFng results demonstrate that modulaFon of the kynurenine pathway consFtutes a promising therapeuFc avenue for design and development of drugs which could delay the onset and reduce the symptoms in a myriad of neurodegeneraFve disorders.
